For Patients

Cancer Treatment Updates

Study estimates number of U.S. women living with metastatic breast cancer

May 17th, 2017

A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population and improvements in treatment.

Read More

Annual Report to the Nation: Cancer death rates continue to decline

March 30th, 2017

According to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014, overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups. But more work remains for some cancers.

Read More

NCI launches study of African-American cancer survivors

February 26th, 2017

The Detroit Research on Cancer Survivors (ROCS) study, which will include 5,560 cancer survivors, will look at the major factors affecting cancer progression, recurrence, mortality, and quality of life among African-American cancer survivors.

Read More

Study finds premature death rates diverge in the United States by race and ethnicity

January 24th, 2017

Premature death rates declined among Hispanics, blacks, and Asian/Pacific Islanders due mainly to fewer deaths from cancer, heart disease, and HIV. Rising deaths from accidents, drug overdoses, suicide and liver disease increased rates among whites and American Indian/Alaska Natives.

Read More

TCGA study identifies genomic features of cervical cancer

January 22nd, 2017

Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified novel genomic and molecular characteristics of cervical cancer that will aid in subclassification of the disease and may help target therapies that are most appropriate for each patient.

Read More

New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials

January 10th, 2017

The National Cancer Institute (NCI) today launched a new drug formulary (the “NCI Formulary”) that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials. The NCI Formulary could ultimately translate into speeding the availability of more-effective treatment options to patients with cancer.

Read More

Early-phase trial demonstrates shrinkage in pediatric neural tumors

December 27th, 2016

In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.

Read More

Cellular Immunotherapy Targets a Common Human Cancer Mutation

December 6th, 2016

In a study of an immune therapy for colorectal cancer that involved a single patient, researchers identified a method for targeting the cancer-causing protein produced by a mutant form of the KRAS gene.

Read More

No Safe Level of Smoking: Even low-intensity smokers are at increased risk of earlier death

December 4th, 2016

People who consistently smoked an average of less than one cigarette per day over their lifetimes had a 64 percent higher risk of earlier death than people who never smoked.

Read More

NCI collaborates with Multiple Myeloma Research Foundation

September 27th, 2016

The National Cancer Institute (NCI) announced a collaboration with the Multiple Myeloma Research Foundation (MMRF) to incorporate MMRF's wealth of genomic and clinical data on the disease into the NCI Genomic Data Commons (GDC), a publicly available database.

Read More

 1 2 3 >  Last ›